AGTPBP1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.582450E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.460100E-02
Normal-vs-Stage2
7.185300E-04
Normal-vs-Stage3
9.244100E-02
Normal-vs-Stage4
1.826800E-01
Stage1-vs-Stage2
9.576800E-01
Stage1-vs-Stage3
6.604200E-02
Stage1-vs-Stage4
2.191000E-01
Stage2-vs-Stage3
6.076400E-02
Stage2-vs-Stage4
2.073000E-01
Stage3-vs-Stage4
7.977500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.018400E-03
Normal-vs-AfricanAmerican
2.209900E-02
Normal-vs-Asian
1.117500E-02
Caucasian-vs-AfricanAmerican
4.089600E-01
Caucasian-vs-Asian
4.873400E-01
AfricanAmerican-vs-Asian
7.832200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.565800E-04
Normal-vs-Female
5.760100E-03
Male-vs-Female
1.959190E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.213410E-01
Normal-vs-Age(41-60Yrs)
1.134460E-02
Normal-vs-Age(61-80Yrs)
1.300120E-03
Normal-vs-Age(81-100Yrs)
4.624800E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.724600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.902000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.064000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.572100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.397400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.098000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.821300E-04
Normal-vs-Daily Drinker
1.058560E-03
Normal-vs-Weekly Drinker
4.317300E-03
Normal-vs-Occasional Drinker
1.035190E-01
Normal-vs-Social Drinker
1.136360E-01
Non Drinker-vs-Daily Drinker
6.703600E-01
Non Drinker-vs-Weekly Drinker
6.196400E-01
Non Drinker-vs-Occasional Drinker
1.806370E-01
Non Drinker-vs-Social Drinker
1.765610E-01
Daily Drinker-vs-Weekly Drinker
4.234400E-01
Daily Drinker-vs-Occasional Drinker
1.249770E-01
Daily Drinker-vs-Social Drinker
1.239770E-01
Weekly Drinker-vs-Occasional Drinker
3.422400E-01
Weekly Drinker-vs-Social Drinker
3.208800E-01
Occasional Drinker-vs-Social Drinker
9.358800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.841800E-01
Normal-vs-Grade 2
2.308400E-01
Normal-vs-Grade 3
7.142000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.483600E-01
Grade 1-vs-Grade 3
4.609400E-01
Grade 1-vs-Grade 4
3.841800E-01
Grade 2-vs-Grade 3
3.521000E-01
Grade 2-vs-Grade 4
2.308400E-01
Grade 3-vs-Grade 4
7.142000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.057490E-03
Normal-vs-NonDiabetic
2.502000E-03
Diabetic-vs-NonDiabetic
6.006000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.483510E-03
Normal-vs-NoPancreatitis
2.700200E-03
Pancreatitis-vs-NoPancreatitis
1.801580E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.826050E-02
Normal-vs-N1
5.411800E-04
N0-vs-N1
2.991200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.114800E-01
Normal-vs-TP53-NonMutant
4.059600E-02
TP53-Mutant-vs-TP53-NonMutant
1.682990E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
